Generic drug
Metformin / saxagliptin price, strengths & recalls
Pharmacies pay $150.48 for 30 tablets of Metformin / saxagliptin 1000 mg / 2.5 mg (24 hr) extended-release tablet this week, and from $150.48 to $281.72 across its 2 priced strengths and forms. 2 manufacturers make it. Its official label last changed on September 2, 2026.
Generic- Fair cash price
- $183.55
- Strengths
- 2
- Makers
- 2
- Updated
- Nov 11
Metformin / saxagliptin price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 1000 mg / 2.5 mg (24 hr) extended-release tablet | $5.02 | $150.48 / 30 tablets |
| 1000 mg / 5 mg (24 hr) extended-release tablet | $9.39 | $281.72 / 30 tablets |
Supply status: shortages & recalls
What people paid for Metformin / saxagliptin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS.SAXAGLIPTIN and METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 2010
WARNING: LACTIC ACIDOSIS
• Post-marketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (> 5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL [see Warnings and Precautions (5.1)].
• Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment, and mitochondrial diseases [see Warnings and Precautions (5.1)].
• Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the full prescribing information [see Dosage and Administration (2.2), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), and Use in Specific Populations (8.6, 8.7)].
• If metformin-associated lactic acidosis is suspected, immediately discontinue saxagliptin and metformin hydrochloride extended-release tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see Warnings and Precautions (5.1)].
WARNING: LACTIC ACIDOSIS
See full prescribing information for complete boxed warning.
• Post-marketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (5.1)
• Risk factors include renal impairment, concomitant use of certain drugs, age >65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (5.1)
• If lactic acidosis is suspected, discontinue saxagliptin and metformin hydrochloride extended-release tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (5.1)
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES SECTION
Boxed Warning 03/2026
Warnings and Precautions (5.1) 03/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 2 approved generic applications on the market
Metformin / saxagliptin questions
How much does metformin / saxagliptin cost without insurance?
Pharmacies pay about $150.48 for 30 tablets of metformin / saxagliptin 1000 mg / 2.5 mg (24 hr) extended-release tablet ($5.02 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $183.55. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is metformin / saxagliptin in shortage?
No shortage is reported for metformin / saxagliptin right now. We check the national shortage list every day.
Has metformin / saxagliptin been recalled?
No recalls are on record for metformin / saxagliptin.
When did the metformin / saxagliptin label last change?
The official label was last updated on September 2, 2026 (version 9). See what changed.
Talk about metformin / saxagliptin
No comments yet. Questions, tips, what worked for you - start the conversation.